Researchers challenge genetic tests for guiding psychiatric treatment

May 23, 2018, McLean Hospital

In a paper published in JAMA Psychiatry, McLean Hospital's Program for Neuropsychiatric Research director Bruce M. Cohen, MD, Ph.D., and his colleagues, George S. Zubenko, MD, Ph.D., University of Pittsburgh School of Medicine (retired), and Barbara R.M. Sommer, MD, Stanford University School of Medicine, emerita, reviewed the scientific basis and effectiveness of pharmacogenetic (Pgen) tests in guiding the choices and doses of psychiatric medications for treating major depressive disorder (MDD) and related psychiatric conditions.

The , "On the Marketing and Use of Pharmacogenetic Tests for Psychiatric Treatment," comes at a time when a growing industry is vigorously marketing Pgen tests by claiming their results can improve the outcomes of patients with . According to the paper, one company website reported having already sold over 650,000 Pgen tests, with an estimated cost of $1 billion in genotyping and related clinical services.

As noted by Zubenko, the first author of the paper, "While the promise of Pgen-guided medication treatment of psychiatric disorders is appealing and supports the popular narrative of personalized/precision medicine, available evidence suggests that Pgen testing will not contribute much to improving care, if at all. And, in some cases, it could provide misleading information."

Citing the genomic evidence on psychiatric disorders, including MDD, the researchers raised questions about the likelihood that Pgen tests would predict either MDD or how patients will respond to treatment. This assessment arises from the very nature of the condition. As described in the paper, MDD is determined by a very large number of genes, and no single gene or limited gene set, even those for drug metabolism and drug targets, determine more than a few percent of the risk of illness or course of treatment, except in rare cases. Rather than genes, demographic and environmental factors, general health, clinical characteristics (psychiatric symptoms, severity, and comorbidity), and co-medication are usually much more important factors than inherited determinants of drug metabolism and response.

Moreover, the paper noted that while the activity of metabolic enzymes is heritable, extremely rapid or slow metabolism is rare, and dosing should be guided by careful dose choice and monitoring therapeutic and side effects rather than by Pgen results. As for medication choice, the authors pointed out that there are standard evidence-based protocols to assist in clinical decision making.

The authors described multiple significant flaws in the design, implementation, and analysis of the 10 published effectiveness studies. Most studies evaluated by the authors were neither controlled nor blinded, and not a single paper was adequately blinded and properly controlled. In addition, the studies cited in marketing and promotional materials were funded by and included co-authors from the companies that offer Pgen services.

According to the authors, well-designed, controlled, and fully blinded studies are needed to determine whether expensive Pgen-guided care outperforms good care performed by board-certified psychiatrists using published protocols for the treatment of MDD. Efforts should also be made, they said, to minimize or eliminate financial and other conflicts of interest that may arise in the conduct of the studies and analysis of the results.

Zubenko emphasized that "doctors, patients, and family members should understand that the jury is out on whether Pgen testing improves good psychiatric care performed by board-certified psychiatrists." He further observed that "in a time of strained mental health care budgets, it's worth asking whether these federal and private healthcare dollars could be better spent on proven methods of care for patients with mental illnesses."

Cohen noted that "new technologies, when properly tested, should become part of clinical assessment, but Pgen has not passed such tests." He warned that "similar studies of inadequate design only add to the number of Pgen tests performed, not to the quality of the evidence on the value of those tests, and clinicians should be cautious in accepting claims until appropriate studies are performed."

Explore further: Study shows family psychiatric history increases risk of postpartum psychiatric episodes

Related Stories

Study shows family psychiatric history increases risk of postpartum psychiatric episodes

May 7, 2018
A new mother's risk of postpartum psychiatric conditions increases when she has an immediate family member with a psychiatric disorder, especially bipolar disorder, according to research published today in the American Journal ...

Asthma and hay fever linked to increased risk of psychiatric disorders

April 23, 2018
Patients with asthma and hay fever have an increased risk of developing psychiatric disorders, finds a new study published in open-access journal Frontiers in Psychiatry. Almost 11% of patients with common allergic diseases ...

New study launched investigating the impacts of personal genomic testing

March 5, 2012
As genetic risk information plays an increasingly important role in the diagnosis and treatment of many diseases, private companies have made personal genomic testing for these risk factors widely available to the public. ...

Cognitive remediation can be implemented in large systems of psychiatric care

May 3, 2018
Cognitive remediation, an evidence-based, recovery-oriented behavioral intervention for patients with mental illness, can feasibly be implemented in large systems of care, according to researchers at the New York State Psychiatric ...

Studies probe value and impact of direct-to-consumer genetic testing

December 13, 2016
Despite being on the market for nearly a decade, direct-to-consumer (DTC) genetic testing continues to be controversial among experts and raises concerns among health care providers and regulatory agencies. The NIH-funded ...

New method extracts information on psychiatric symptoms from electronic health records

February 26, 2018
Researchers at Massachusetts General Hospital and Harvard Medical School have developed a new method to extract valuable symptom information from doctors' notes, allowing them to capture the complexity of psychiatric disorders ...

Recommended for you

Researchers discover abundant source for neuronal cells

December 13, 2018
USC researchers seeking a way to study genetic activity associated with psychiatric disorders have discovered an abundant source of human cells—the nose.

New genetic clues to early-onset form of dementia

December 13, 2018
Unlike the more common Alzheimer's disease, frontotemporal dementia tends to afflict young people. It accounts for an estimated 20 percent of all cases of early-onset dementia. Patients with the illness typically begin to ...

Video game players frequently exposed to graphic content may see world differently

December 13, 2018
People who frequently play violent video games are more immune to disturbing images than non-players, a UNSW-led study into the phenomenon of emotion-induced blindness has shown.

How teens deal with stress may affect their blood pressure, immune system

December 13, 2018
Most teens get stressed out by their families from time to time, but whether they bottle those emotions up or put a positive spin on things may affect certain processes in the body, including blood pressure and how immune ...

Increased motor activity linked to improved mood

December 12, 2018
Increasing one's level of physical activity may be an effective way to boost one's mood, according to a new study from a team including scientists at Johns Hopkins Bloomberg School of Public Health in collaboration with the ...

How bullying affects the brain

December 12, 2018
New research from King's College London identifies a possible mechanism that shows how bullying may influence the structure of the adolescent brain, suggesting the effects of constantly being bullied are more than just psychological.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.